|
Clinicopathologic features
|
Number (N= 134)
|
DACT1methylation status
|
Pvalue
|
|---|
| | |
Methylated
|
Unmethylated
| |
|---|
|
Age (years)
|
≤40
|
11
|
2
|
9
|
0.229
|
| |
> 40
|
86
|
30
|
56
| |
| |
Unknown
|
37
|
8
|
29
| |
|
Tumor grade
|
I
|
7
|
2
|
5
|
0.425
|
| |
II
|
56
|
21
|
35
| |
| |
III
|
5
|
1
|
4
| |
| |
Unknown
|
66
|
16
|
50
| |
|
Tumor size
|
≤2.0 cm
|
44
|
14
|
30
|
0.21
|
| |
≥2.0 cm, ≤5.0 cm
|
48
|
18
|
30
| |
| |
> 5.0 cm
|
4
|
0
|
4
| |
| |
unknown
|
38
|
8
|
30
| |
|
Lymph node metastasis
|
Positive
|
43
|
16
|
27
|
0.38
|
| |
Negative
|
41
|
12
|
29
| |
| |
Unknown
|
50
|
12
|
38
| |
|
Distant metastasis
|
Positive
|
1
|
1
|
0
|
0.114
|
| |
Negative
|
98
|
32
|
66
| |
| |
Unknown
|
35
|
7
|
28
| |
|
ER status
|
Positive
|
45
|
17
|
28
|
0.274
|
| |
Negative
|
29
|
9
|
20
| |
| |
Unknown
|
60
|
14
|
46
| |
|
PR status
|
Positive
|
34
|
11
|
23
|
0.296
|
| |
Negative
|
40
|
15
|
25
| |
| |
Unknown
|
60
|
14
|
46
| |
|
HER2 status
|
Positive
|
42
|
15
|
27
|
0.148
|
| |
Negative
|
28
|
11
|
17
| |
| |
Unknown
|
64
|
14
|
50
| |
- ER, estrogen receptor; HER2, human epidermal growth factor receptor-2; PR, progesterone receptor.
